Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antisense to c-myc for treatment of polycystic kidney disease

Antisense to c-myc for treatment of polycystic kidney disease

US Patent 6875747 · Granted Apr 5, 2005

Estimated economic value: $3,412,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic mRNA vaccine for malignancies2025
Antisense oligomer compounds2023
Use of TRPV4 antagonists to ameliorate hydrocephalus and related materials and m2022
Multifunctional topical cream comprising beta-caryophyllene, essential oils, in 2021
DsRNA molecules comprising oligonucleotide analogs having modified intersubunit 2021
Compositions for enhancing transport of molecules into cells2021
Antisense composition and method for treating muscle atrophy2020
Renal selective inhibition of cytochrome P450 3A52020
Splice-region antisense composition and method2020
Antisense antiviral compound and method for treating ss/RNA viral infection2019
Use of TRPV4 antagonists to ameliorate hydrocephalus and related materials and m2019
Compositions for enhancing transport of molecules into cells2019